The supplement business in question is a clinically-focused company dedicated to addressing the needs of over five million women in the U.S. diagnosed with Polycystic Ovary Syndrome (PCOS). It boasts a strong reputation with 4.9-star reviews and is backed by nurse-founded and doctor-approved credibility. The product is NSF Certified, ensuring high credibility among consumers and healthcare providers. Over the past year, the company has generated over $115,000 in revenue through platforms like Shopify and Amazon, maintaining a 66% gross margin and less than a 3% return rate. This brand distinguishes itself through its strong community engagement, with around 2,000 cases highlighting its role in conception journeys, evidenced by over 250 reviews across Google and Facebook. Its community includes a substantial following on TikTok and an active email list, though it has yet to fully leverage structured subscription models, affiliate marketing, or performance marketing. The competitive advantages include its clinical credibility, documented conception outcomes, and HSA/FSA eligibility, making it a unique option in a largely untapped market. The potential for growth is significant, with strategies identified for enhancing subscription models, expanding affiliate programs, scaling performance marketing on platforms like Meta and Google, improving Amazon presence, and exploring healthcare partnerships. A prospective buyer will find opportunities for seller financing, with the current owner willing to remain to ensure continued community trust. The business presents a rare acquisition opportunity in the PCOS supplement market, with a proven track record and clear avenues for growth.